It looks like you're offline.
Donate
♥
English (en)
العربية (ar)
Čeština (cs)
Deutsch (de)
English (en)
Español (es)
Français (fr)
हिंदी (hi)
Hrvatski (hr)
Italiano (it)
Português (pt)
Română (ro)
Sardu (sc)
తెలుగు (te)
Українська (uk)
中文 (zh)
Page Status
My Books
Browse
Menu
Subjects
Trending
Library Explorer
Lists
Collections
K-12 Student Library
Book Talks
Random Book
Advanced Search
All
All
Title
Author
Text
Subject
Lists
Advanced
Log In
Sign Up
My Open Library
Log In
Sign Up
Browse
Subjects
Trending
Library Explorer
Lists
Collections
K-12 Student Library
Book Talks
Random Book
Advanced Search
Contribute
Add a Book
Recent Community Edits
Resources
Help & Support
Developer Center
Librarians Portal
My Books
Browse
Menu
Subjects
Trending
Library Explorer
Lists
Collections
K-12 Student Library
Book Talks
Random Book
Advanced Search
Last edited by
ImportBot
September 17, 2023 |
History
Edit
DrugPatentWatch
50 works
Add another?
Most Editions
Most Editions
First Published
Most Recent
Top Rated
Reading Log
Trending
Random
Details
Grid
— Show
only ebooks
?
1
2
3
Next >
XIIDRA Drug Profile 2023: XIIDRA Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
Create a new list
×
Close
Name:
Description:
Create new list
Cancel
SUBOXONE Drug Profile 2023: SUBOXONE Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
HARVONI Drug Profile 2023: HARVONI Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
BREO ELLIPTA Drug Profile 2023: BREO ELLIPTA Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
JENTADUETO XR Drug Profile 2023: JENTADUETO XR Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
NESINA Drug Profile 2023: NESINA Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
EDURANT Drug Profile 2023: EDURANT Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
ONGLYZA Drug Profile 2023: ONGLYZA Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
TIVICAY Drug Profile 2023: TIVICAY Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
JANUMET Drug Profile 2023: JANUMET Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
TRUVADA Drug Profile 2023: TRUVADA Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
NUCYNTA ER Drug Profile 2023: NUCYNTA ER Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
GLYXAMBI Drug Profile 2023: GLYXAMBI Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
BYETTA Drug Profile 2023: BYETTA Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
PREZCOBIX Drug Profile 2023: PREZCOBIX Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
VYVANSE Drug Profile 2023: VYVANSE Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
VIMOVO Drug Profile 2023: VIMOVO Drug Patents, FDA Exclusivity, Litigation, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
XTAMPZA ER Drug Profile 2023: XTAMPZA ER Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
VICTOZA Drug Profile 2023: VICTOZA Drug Patents, FDA Exclusivity, Litigation, Drug Prices, Sales Revenues
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
EPCLUSA Drug Profile 2023: EPCLUSA Drug Patents, FDA Exclusivity, Litigation, Drug Prices
by
DrugPatentWatch
First published in 2023
—
1 edition
Locate
✓
Add to List
Remove From Shelf
Want to Read
Currently Reading
Already Read
My Reading Lists:
Create a new list
1
2
3
Next >
Subjects
Business
,
Medicine
Add to List
My Reading Lists:
Create a new list
ID Numbers
OLID: OL13201281A
Links
outside Open Library
No links yet.
Add one
?
Download catalog record:
RDF
/
JSON